LEADER 04478nam 2201105z- 450 001 9910580209103321 005 20231214132952.0 035 $a(CKB)5690000000011997 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87502 035 $a(EXLCZ)995690000000011997 100 $a20202207d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMechanisms and Novel Therapeutic Approaches for Gynecologic Cancer 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (258 p.) 311 $a3-0365-4383-X 311 $a3-0365-4384-8 330 $aThis book?entitled ?Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer??was edited as a Special Issue of Biomedicines, focusing on basic research such as genomics, epigenomics, and proteomics, as well as clinical research in the field of gynecologic oncology. The number of patients with gynecological cancer has been increasing worldwide due to its high lethality and lack of early detection tools and effective therapeutic interventions. In this regard, basic research on its pathophysiology and novel molecular targeting intervention is required to improve the prognosis of gynecologic cancer. This book contains 13 papers, including 8 original research papers and 5 reviews focusing on the basic research of gynecologic oncology. The reader can learn about state-of-the-art research and obtain extensive knowledge of the current advances in the field of gynecologic oncology. It is my hope that this book contributes towards the progress of gynecologic oncology. 606 $aPublic health & preventive medicine$2bicssc 610 $anucleus accumbens-associated protein 1 (NAC1) 610 $aBEN (BANP, E5R and NAC1) domain 610 $asequence-specific DNA-binding protein 610 $asolution NMR structure 610 $aisothermal titration calorimetry (ITC) 610 $ahuman cytomegalovirus 610 $aovarian cancer 610 $acancer progression 610 $ainflammation 610 $aimmunosuppression 610 $aendometrial carcinoma 610 $aimmune micro-environment 610 $aimmune checkpoints inhibitors 610 $amicrosatellite instability 610 $amismatch repair deficiency 610 $aplatelet-activating factor acetylhydrolase (PAF-AH 610 $aPLA2G7) 610 $aBRCA1 mutant ovarian cancer 610 $aWnt signaling 610 $apGSK3? 610 $a?-catenin 610 $aprognosis 610 $avulvar melanoma 610 $avaginal melanoma 610 $atargeted therapy 610 $agynecological cancer 610 $amelanoma treatment 610 $agene ontology 610 $aepithelial ovarian cancers 610 $aborderline ovarian tumors 610 $adifferentially expressed genes 610 $aaryl hydrocarbon receptor 610 $aepithelial-mesenchymal transition 610 $aintegrative analysis 610 $atestin 610 $ap16 protein 610 $acervical cancer 610 $acervical neoplasia 610 $aimmunohistochemistry 610 $achimeric antigen receptor 610 $aCD44 610 $aadoptive immunotherapy 610 $aNK cells 610 $aepithelial ovarian cancer 610 $aDNA damage response 610 $asomatic mutation 610 $aclear cell carcinoma 610 $aendometrioid endometrial cancer 610 $aDNA mismatch repair (MMR) 610 $aMMR deficient (dMMR) 610 $along-term survival 610 $aexosome 610 $amiRNA 610 $abiomarkers 610 $aliquid biopsy 610 $ainterventional radiotherapy 610 $avaginal-cuff brachytherapy 610 $aHDR brachytherapy 610 $ain vivo dosimetry 610 $aendometrial cancer 610 $abiological planning 610 $adrug repurposing 610 $anon-coding RNAs 610 $ananocarriers 610 $aanti-angiogenic therapy 615 7$aPublic health & preventive medicine 700 $aNakayama$b Naomi$4edt$01326272 702 $aNakayama$b Naomi$4oth 906 $aBOOK 912 $a9910580209103321 996 $aMechanisms and Novel Therapeutic Approaches for Gynecologic Cancer$93037242 997 $aUNINA